Disposal of four care homes for £44.5 million
![](https://tracker.live.rns-distribution.com/track.live-rns/5241394_d9353a075fe0b610698e373da828b7e4.png)
27 June 2024
Target Healthcare REIT plc and its subsidiaries
("Target Healthcare" or "the Group")
Disposal of four care homes for £44.5 million
Target Healthcare (LSE: THRL) announces that it has completed the disposal of four UK care homes for £44.5 million to the incumbent tenant. The sale price reflects a modest premium to the portfolio's carrying value at both 31 December 2023 (the latest date prior to the offer being received) and 31 March 2024, and an implied net initial yield of 5.64%.
Proceeds from the disposal, which represented 326 beds and c.4.6% of the Group's overall portfolio value, will enable a partial repayment of the Group's revolving credit facilities and therefore reduce its unhedged interest cost. Overall, the disposal reduces net LTV by approximately 3.8%.
These assets were originally constructed in 2007/08, and were consequently amongst the oldest assets in the Group's portfolio, and had a c.12% lower gross internal floor space per resident than the portfolio's weighted average. In addition, these assets represented the Group's four shortest lease terms, with an average of 13.6 years remaining. Following the disposal, the portfolio's weighted average unexpired lease term increases to 26.3 years from 25.8 years, and the Group's weighting to Yorkshire and the Humber reduces, an area that was previously its largest geographical exposure.
These properties were originally acquired as part of the significant portfolio acquisition in December 2021. Despite the relatively short holding period for a property investment, this disposal enabled the Company to crystalise significant value from these assets, resulting in an annualised ungeared IRR in excess of 7% over the period of ownership (including both acquisition and sales costs) and is a testament to the Group's asset management expertise.
Scott Steven, Head of Asset Management at Target Fund Managers, commented:
"These care homes have been a successful investment for the Group, delivering a consistent and attractive rental yield over the period of ownership, combined with the realisation of a capital uplift on disposal. We care deeply about the quality of our assets and the services they facilitate; however we are not unduly attached to holding onto the bricks and mortar where we identify opportunities to improve both the overall portfolio and the Group's capital structure. This disposal is a clear illustration of our ability to pro-actively manage the portfolio to provide an attractive and sustainable level of income, together with the potential for growth, from our diversified portfolio of modern, purpose-built care homes."
LEI: 213800RXPY9WULUSBC04
All enquiries:
Target Fund Managers Limited Kenneth MacKenzie / Gordon Bland
| 01786 845 912 |
Stifel Nicolaus Europe Limited Mark Young / Rajpal Padam / Catriona Neville
| 020 7710 7600 |
FTI Consulting Dido Laurimore / Richard Gotla / Talia Shirion | 020 3727 1000 |
Notes to editors:
UK listed Target Healthcare REIT plc (THRL) is an externally managed Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfolio of modern, purpose-built care homes.
The Group's portfolio at 31 March 2024 comprised 98 assets let to 33 tenants with a total value of £934.8 million.
The Group invests in modern, purpose-built care homes that are let to high quality tenants who demonstrate strong operational capabilities and a strong care ethos. The Group builds collaborative, supportive relationships with each of its tenants as it believes working in this way helps raise standards of care and helps its tenants build sustainable businesses. In turn, that helps the Group deliver stable returns to its investors.
Important information
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the Market Abuse Regulations (EU) No. 596/2014, which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via Regulatory Information Service, this inside information is now considered to be in the public domain.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.